Building Better Beta Cells

Edouard Stanley, Andrew George Elefanty

    Research output: Contribution to journalArticleResearchpeer-review

    8 Citations (Scopus)


    Type 1 diabetes represents an attractive target for human embryonic stem cell (hESC)-based cell replacement therapies. Recently, in Nature Biotechnology, Kroon et al. (2008) reported encouraging progress toward this goal with the development of functional islet-like structures in mice transplanted with hESC-derived pancreatic endoderm.
    Original languageEnglish
    Pages (from-to)300 - 301
    Number of pages2
    JournalCell Stem Cell
    Issue number4
    Publication statusPublished - 2008

    Cite this